Vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC): technique and mean 20 months outcomes
Authors:
Open Access
- 15 December 2020
- journal article
- research article
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 47 (6) , 887-894
Abstract
The main purpose of our study is to evaluate the efficacy and safety of vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC) for apical pelvic organ prolapse. We retrospectively reviewed the results of twenty-three women with stage III and IV prolapse treated with VALSAC between April 2017 and June 2019. With a mean follow-up of 20 months, apical pelvic organ prolapse was cured in 95.7 % of patients. There was no complication in terms of mesh exposure, persistent pain, hematoma, infection. The mean pre- and post-operative POP-Q scores were, for the Aa point, 1.61 ± 1.82 cm and -1.96 ± 0.87 cm (p < 0.01), for the C point, 2.87 ± 1.6 cm and -5.26 ± 1.86 cm (p < 0.01) for the Ap point, -1.43 ± 0.89 cm and -2.09 ± 0.59 cm (p < 0.01). VALSAC is a promising minimally invasive technique for pelvic floor reconstruction that appears to provide good outcomes. Content: The main purpose of our study is to evaluate the efficacy and safety of vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC) for apical pelvic organ prolapse.Keywords
This publication has 4 references indexed in Scilit:
- Robot‐assisted surgery for the management of apical prolapse: a bi‐centre prospective cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2019
- Robotic Sacrocolpopexy—Is It the Treatment of Choice for Advanced Apical Pelvic Organ Prolapse?Current Urology Reports, 2017
- Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the anterior compartmentInternational Urogynecology Journal, 2013
- Nonobstetric Risk Factors for Symptomatic Pelvic Organ ProlapseObstetrics & Gynecology, 2009